Infections with non-B HIV-1 subtypes are rare in the United States, but comprise a significant percentage of infections among U.S. military personnel. Risk behavior while on overseas deployment correlates with non-B infection in this population. Extensive genetic characterization will be required to define HIV-1 diversity, and to effectively evaluate requirements for HIV-1 vaccines and other prevention strategies in this group. From 1997 to 2000, 520 recent seroconverters, identified through routine HIV-1 testing in the U.S. active military force, volunteered for a prospective study. V3 loop serology or partial genome sequencing identified 28 non-B subtype infections; 14 were studied by full genome sequencing and phylogenetic analysis. Five strains were CRF01_AE. Four of these clustered with CM240 from Thailand, and one clustered with African CRF01_AE. Four strains were CRF02_AG, prevalent in West and West Central Africa. Two strains were subtype C. One strain was a unique recombinant between CRF01_AE and subtype B, and another was a complex unique recombinant between subtype A and D. The final strain was a member of a complex circulating recombinant first identified in Senegal, CRF09_cpx, incorporating subtypes A, F, G, and an unclassified genome. This diversity of non-B subtype HIV-1 strains, encompassing three globally prevalent non-B strains and including rare or even possibly unique strains, illustrates the breadth of U.S. military exposure while deployed and sets the bar higher for breadth of cross-subtype protection to be afforded by an HIV-1 vaccine.
in the late 1970s and the early 1980s among gay men in San Francisco and New York City. 4, 5 The identification of HIV-1 first occurred with these patients 6, 7 later classified as HIV-1 subtype B. This virus strain also spread in intravenous drug users, heterosexual, and other populations over time and became the most prevalent strain in North America. 2 Although different U.S. populations may have different risk behaviors, the most common infecting strain is subtype B. Nonetheless, it has occasionally been reported that other HIV-1 subtypes are present, albeit in very low numbers, in the United States. [8] [9] [10] [11] [12] Most of these infections were acquired outside the United States or through contact with infected persons from foreign countries.
U.S. military personnel are a unique population, with virtually worldwide potential for deployments and duty stations. Since 1985, periodic screening for HIV has allowed early identification of HIV infections in U.S. military personnel, with counseling and state of the art clinical management, and HIV-1-positive U.S. military personnel are not deployed.
The vaccine requirements for military personnel often differ from the general U.S. population, and HIV-1 vaccine may follow this paradigm. While a subtype B HIV-1 vaccine would be most genetically matched to most military and civilian U.S. HIV-1 infections, the non-B infections in the military constitute a significant percentage that could expand with increasing international engagement on the ground. To anticipate this need, the best available strategy is to study the breadth of strains acquired through current deployments and to study the active force prospectively. Here we report full characterization of 14 non-B strains, the first detailed analysis of the non-B risk to U.S. forces.
Between February 1997 and May 2000, 520 out of 701 recent seroconverters, identified through routine HIV-1 testing in U.S. military personnel, volunteered for a longitudinal evaluative study. The study has been described in detail elsewhere. 11 A competitive-binding enzyme immunoassay (EIA) with V3 loop peptides was employed to screen for non-B subtype. 13 Further confirmation was performed either by sequence analysis of envelope C2-V5 from peripheral blood mononuclear cell (PBMC) DNA or by a gene chip assay from extracted serum viral RNA. Of 520, 28 (5.4%) were non-B subtype. By partial or complete genome analysis, they were 17 CRF01_AE, 6 CRF02_AG, 2 subtype C, 1 CRF01_AE/B recombinant, 1 subtype D, and a complex intersubtype recombinant. Of the 28 non-B subtypes, 14 were subselected from the preliminary genotyping assays for full genome sequencing and analysis.
DNA was extracted from PBMC using QIAmp blood extraction kits (QIAgen, Valencia, CA). A nested polymerase chain reaction (PCR) with near-endpoint dilution of DNA template in the first round was performed to recover a full-length HIV-1 genome from PBMC DNA using the procedures previously described. 14, 15 Primers for the first round PCR were MSF12b (5Ј-AAATCTCTAGCAGTGGCGCCCGAACAG-3Ј) in the 5Ј long terminal repeat (LTR) region and OFMR1 (5Ј-TGAGGGATCTCTAGTTACCAGAGTC-3Ј) in the 3Ј LTR region. The second round primers were F2NST (5Ј-GCGGAG-GCTAGAAGGAGAGAGATGG-3Ј) in the U5 region of the 5Ј LTR and OFM19 (5Ј-GCACTCAAGGCAAGCTTTATTGAG-GCTTA-3Ј) at the end of the U3 region of the 3Ј LTR. PCR products from the nested reaction were purified and either cloned for sequencing or directly sequenced from the PCR product.
Full-length genomic DNAs were cloned using TOPO XL PCR Cloning Kit (Invitrogen Life Technologies, Carlsbad, CA). Briefly, the nested PCR product was gel purified on a 0.8% agarose gel. The purified product was excised, isolated, and ligated with pCR-XL-TOPO Vector as instructed by the supplier. Two microliters of ligation reaction was transformed into MAX EFFICIENCY Stabl2 Competent Cells (Invitrogen Life Technologies, Carlsbad, CA). Positive clones were screened using a 32 P-labeled gag (OFM3; 5Ј-ATCCTGGGATTAAATAA-AATAGTAAGAATGTATA-3Ј) and env (OFM6; 5Ј-ACG-GTACAGGCCAGACAATTATTGTCTGGTATAGT-3Ј) probes using a standard colony screening procedure. 16 Plasmid DNA or purified PCR products were sequenced using BigDye terminator reaction kits and an ABI 373 DNA sequencer with XL upgrade and the ABI Prism BigDye Filter Wheel (PE Applied Biosystems, Foster City, CA). DNA sequences were assembled using Sequencher software version 3.1 (Genecodes Inc., Ann Arbor, MI).
Sequences were aligned with reference sequences of known HIV subtypes; subtype A (92UG037, UGSE7535, and Q2317), subtype B (RF, MN, and RL42), subtype C (ETH2220, 92BR025, 98TZ013, 96ZM651, 93IN905, and 94IN11246), subtype D (Z2Z6, ELI, NDK, and 94UG114), CRF01_AE (CM240, 93TH253, 97CNGX_11F, and 90CF402), CRF02_AG (IbNG and DJ263), subtype F (93V1850 and FIN9363), subtype G (SE6165 and HH8793), subtype H (90CF056 and V1991), subtype J (SE9173.3 and SE9280.9), and CRF09_cpx (95SN1795, 95SN7808, and 96GH2911). 1 Phylogenetic trees were constructed and the consistency was evaluated using SEQBOOT, DNADIST (Kimura 2-parameter with a transition/transversion ratio 2.0), NEIGHBOR, CON-SENSE, and DNAPARS modules of the Phylip Package (V3.52c) 17 and TREETOOL. 18 Recombinant strains were identified and breakpoints were mapped with maximum parsimony bootscan using 300-nt windows overlapping by 50 nt. 19 Breakpoints were confirmed by Recombinant Breakpoint Analysis software. 20 The recombinant genome was broken into segments at the breakpoints and a phylogenetic analysis of each segment was performed with a neighbor-joining tree with the bootstrap. Bootstrap values of 70% or greater confirmed the subtype of individual segments.
The HIV-1 strains were obtained from U.S. military personnel who seroconverted between 1996 and 2000 ( Table 1 ). They were primarily men (n ϭ 13), with a mean age of 35.8 Ϯ 8.5 (SD) years (range 25-57) and of African-American (n ϭ 7), white (n ϭ 5), and Hispanic (n ϭ 1) ethnicity. Only one female was in this group, a 23-years-old African-American. They gave a history of having heterosexual exposures, with 10 out of 12 (83%) reporting sex outside the United States. Their foreign exposures included several distinct HIV-1 epidemic areas, ranging from the Far East, Southeast Asia, the Middle East, Western Europe, and West Africa. Absolute CD4 lymphocyte counts of these subjects were 450 Ϯ 62 (mean Ϯ SE), with a range of 150-874 cells/l.
A neighbor-joining tree is depicted in Fig. 1A . Strains MSC1100, 1120, 1164, 2008, and 3012 clustered with CRF01_AE reference sequences (bootstrap value 95%). There were two monophyletic groups among CRF01_AE. MSC2008 formed a separate group with CF402, an African strain (100% bootstrap), while the others clustered (100% bootstrap) with Thai strains (CM240 and TH253) and with CNGX_11F from China. The intersubject nucleotide distance of the four Thai CRF01_AE strains was 4.3% over the full genome, and gag, pol, and envelope gene diversity were 4.1%, 3.0%, and 5.7%, respectively. Two subtype C strains, MSC3018 and 5016, clustered with the subtype C reference sequences (100% bootstrap). The new subtype C sequences, together with some reference sequences from Africa and India, formed a monophyletic group separate from the Brazilian and Ethiopian C strains. MSC1134, 3083, 4041, and 5007 were assigned to CRF02_AG with a bootstrap value of 80%. These CRF02_AG strains were more diverse than the CRF01_AE strains, with intersubject nucleotide distances of 8.4% for the whole genome, 6.9% in gag, 6.2% in pol, and 11.6% in envelope. The remaining three strains were recombinants.
The first recombinant, MSC4057, clustered with three CRF09_cpx strains from West Africa, which has a very complex structure containing subtypes A, F, G, and some unclassified regions. There were at least 12 shifts in subtype across the genome of MSC4057 and the other CRF09_cpx, located in gag, pol, env, vpr, and tat/rev coding regions, respectively. These four strains were recently classified as CRF09_cpx. 21 The two other recombinants combined subtypes A and D, and CRF01_AE and B, respectively. Neither of them corresponded to any known CRF; hence they are classified as URFs. By bootscan analysis using two parental subtypes identified in Uganda (99UGA07072 as subtype A and 94UG1141 as subtype D) it was determined that MSC4068 was a unique recombinant form between subtypes A and D, with five crossover points (Fig. 1B, top panel) . The first fragment of the genome belonged to subtype D (100% bootstrap value) starting from p17 in gag and encompassing p24, p2, p7, p1, p6, protease, RT, RNaseH, and part of integrase. The second fragment clustered with subtype A, with a bootstrap value of 69%. It encoded part of integrase, vif, and part of vpr. The genome again shifted to subtype D, forming a monophyletic group with strain 99UG1141 at a bootstrap value of 82%, in the region encoding part of vif, vpr, and tat1. The fourth fragment was too small to assign to either parent subtype, about 204 nt in length. A visual inspection of the alignment showed mostly subtype A genetic material. The next fragment was subtype D (bootstrap 80%), encompassing vpu and the beginning of envelope. The last fragment consisted of most of env, partial nef, and part of 3Ј LTR, and was of subtype A (100% bootstrap). The last strain identified was MSC5043, a recombinant containing CRF01_AE and subtype B. It had three crossover points, two in pol and another in vif, breaking the genome into four fragments (Fig. 1B,  bottom panel) . The first fragment, from the beginning of gag up to near the end of RnaseH, was subtype B (bootstrap 100%). The genome shifted to CRF01_AE through approximately 80% of integrase. This second fragment clustered with CM240 and TH253 with the bootstrap value of 100%. Subtype B was as- signed in the next region (bootstrap 99%). This region contained the rest of integrase and more than half of vif. The last fragment was CRF01_AE (100% bootstrap) encoding 36 amino acids at the 3Ј end of vif, vpr, tat1/2, rev1/2, vpu, gp160, partial nef, and partial 3Ј LTR. Demographic characteristics in this study included a large age range, broad ethnicity, and geographic risk exposure. Not surprisingly, only one was female, consistent with the 8-12% of females in U.S. military personnel. African-Americans were overrepresented, similar to data reported in the overall HIV-1 incidence in military personnel, 1985-1999. 22 The complete genome characterization of these strains is almost a miniature of the global HIV-1 pandemic, including the globally prevalent subtype C, CRF01_AE, and CRF02_AG, alongside rare CRF09_cpx and even URF A/D and 01/B. The U.S. military personnel from whom HIV-1 sequences were derived had broad geographic exposures. Of note, 83% of the infections with international exposure were consistent with the predominant subtypes circulating in the area where the exposure occurred: four Thai CRF01_AE and one URF_01/B in Southeast Asia and four CRF02_AG in West Africa. However, some strains, such as the African CRF_01AE and CRF09_cpx that are relatively rare and apparently endemic only in certain areas, were also identified. The study provides the first evidence suggesting the wider spread of African CRF01_AE outside Central Africa where it was found exclusively. 23, 24 CRF09_cpx has only been found previously in Senegal, 21 but was in the U.S. military person with foreign exposure in Germany. URF_AD should be identified in the area where subtypes A and D are circulating, like East Africa. 25 The AD recombinant found in Germany, MSC 4068, reflects an East African origin, but was most likely obtained in Germany. This diversity of HIV-1 is similar to that recently reported in an immigrant population in New York City. The diversity of non-B subtypes in this civilian population was also broad, and the strain in each individual usually was a predominant subtype in the exposure area. 26 The concordant findings between these two unique populations, immigrants and deployed U.S. military personnel, suggest a continuing influx of non-B strains into the United States, and, collectively, the incoming viruses can be as genetically diverse, if not more so, than in any single part of the world.
These results reemphasize the challenges that must be faced to develop an effective HIV-1 vaccine for populations, such as the U.S. military with worldwide exposure. Of note, the most frequently identified non-B strains in this study were Thai CRF01_AE and West African CRF02_AG strains. The ongoing phase III vaccine efficacy trial in Thailand and phase I/II trials in Africa, respectively, will address these strains directly and will be of clear benefit to the U.S. military vaccine development effort.
The GenBank accession number of MSC 4068 is AY09360. The other sequences are available under GenBank accession numbers AY444799 to AY444801 and AY444803 to AY444812.
